HP
EstablishedHaptoglobin helps distinguish hemolytic from non-hemolytic anemia by reflecting free hemoglobin clearance.
Haptoglobin mops up free hemoglobin released when red blood cells break apart. Low levels are a good clue for hemolysis (red cell destruction), though inflammation elsewhere in the body can mask this by keeping haptoglobin falsely normal.
Haptoglobin is a liver-produced protein that binds free hemoglobin released during red blood cell breakdown, serving as a key marker for distinguishing hemolytic from non-hemolytic anemia.
Low haptoglobin alongside anemia points toward hemolysis (red cell destruction), since haptoglobin gets rapidly consumed and cleared when binding free hemoglobin; it is interpreted alongside LDH (elevated) and indirect bilirubin (elevated) as a hemolysis panel.
Measured via serum immunoassay; haptoglobin is also an acute-phase reactant, so it can be falsely normal or elevated in a patient with both hemolysis and concurrent inflammation, a diagnostic trap worth recognizing.
Confirmed hemolysis prompts further workup for the underlying cause (autoimmune hemolytic anemia, mechanical heart valve, G6PD deficiency, hereditary spherocytosis, etc.), guiding specific treatment.
Can be falsely normal in patients with concurrent inflammation, since it is also an acute-phase reactant.
- General hematology reference literature on the hemolysis workup (haptoglobin, LDH, bilirubin, reticulocyte count).